Introduction
The ATP-binding cassette (ABC) transporter superfamily plays important roles in drug absorption and disposition. ABC transporters were originally implicated in multidrug resistance in tumor cells (Sarkadi et al., 2006) . Further research has demonstrated that these transporters are distributed throughout many normal tissues of the body. For instance, P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 2 (MRP2/ABCC2), and breast cancer resistance protein (BCRP/ABCG2) exist on the apical membrane of intestinal epithelia and function as a defense system against xenobiotics (Benet et al., 1996; Borst et al., 2000; Maliepaard et al., 2001; Leslie et al., 2005) . P-gp, MRP2, and BCRP have been reported to have well-defined roles in the transport of clinically relevant drugs and to mediate cellular resistance to these drugs (Leslie et al., 2005; Litman et al., 2001 ). These ABC transporters can transport diverse substrates to the outside of cellular membranes using the hydrolytic energy of ATP as a driving force (Litman et al., 2001) .
Recently, the possibility of drug interactions has been increasing due to multiple and complex medications, and significant revisions of safety profiles in the product information have been frequently undertaken in clinical practice (Yoshida et al., 2006 c ). Moreover, herbal medicine and diet supplements made from natural products are widely used in patients treated with conventional prescription medicines.
Recent advancements in biopharmaceutical research have revealed physiological and pharmacological aspects of transporters, however, drug interactions with other drugs, endogenous substrates, and food ingredients have not been fully clarified.
Previously, we investigated possible interactions between Japanese traditional herbal medicines and conventional medicines (Kawakami et al., 2002) , and reported that an extract of Zanthoxyli Fructus and some terpenoids can inhibit P-gp-mediated efflux transport in vitro and in vivo (Yoshida et al., 2005; Yoshida et al., 2006 b ). In the present study, the inhibitory effects of seven terpenoids (Fig. 1 ) that which can be P-gp inhibitors ) on MRP2-and BCRP-mediated transport were investigated using membrane vesicles. This article has not been copyedited and formatted. The final version may differ from this version. H]E 2 17βG (100 nM) into vesicles were examines using a rapid filtration technique (Suzuki et al, 2003) . Radioactivity retained on the filter (HAWP; Millipore Corp., Bedford, MA) was determined using a liquid scintillation counter (TRI-CARB 2100TR, Packard Inst. Co., Meriden, CT).
Statistical analysis
All data are presented the mean with SEM of three experiments. Significant differences between the control and inhibitor data were determined by Bonferroni's multiple t-test. The IC 50 and its 95% confidence interval were calculated by probit analysis. P values of <0.05 were considered to be statistically significant. This article has not been copyedited and formatted. The final version may differ from this version. (open column in Fig. 4 ) under our experimental conditions. Even if BCRP-mediated transport of [ 3 H]E 2 17βG is fully blocked by glycyrrhetic acid, the change in the net transport will be relatively small.
Moreover, IC 50 value of glycyrrhetic acid for MRP2 (20 µM) is smaller than that for BCRP (39 µM). These findings suggest that glycyrrhetic acid is a potent inhibitor of MRP2 but less potent inhibitor of BCRP among terpenoids tested in this study.
In this study, MRP2 transport was inhibited by glycyrrhetic acid and abietic acid, while BCRP transport was inhibited by only glycyrrhetic acid.
(R)-(+)-citronellal, (S)-(-)-β-citronellol, α-terpinene,
terpinolene, and (-)-β-pinene did not affect these transporters. Previously, we reported that all terpenoids used in this study can inhibit P-gp ( In conclusion, we have demonstrated that glycyrrhetic acid can inhibit not only P-gp but also MRP2 and BCRP. Abietic acid can also inhibit P-gp and MRP2. Abietic acid and glycyrrhetic acid may interact with P-gp, MRP2 or BCRP substrates and change their absorption and disposition.
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